Rahman M, Spitzhorn L, Wruck W, Hagenbeck C, Balan P, Graffmann N, et al. The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time. Stem Cell Res Ther. 2018;9:113 pubmed publisher

Simara P, Tesarova L, Rehakova D, Farkas S, Salingova B, Kutalkova K, et al. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells. Stem Cells Dev. 2018;27:10-22 pubmed publisher

Buonocore F, Kühnen P, Suntharalingham J, Del Valle I, Digweed M, Stachelscheid H, et al. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest. 2017;127:1700-1713 pubmed publisher

Charpentier M, Khedher A, Menoret S, Brion A, Lamribet K, Dardillac E, et al. CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair. Nat Commun. 2018;9:1133 pubmed publisher

Spitzhorn L, Rahman M, Schwindt L, Ho H, Wruck W, Bohndorf M, et al. Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections. Stem Cells Int. 2017;2017:5932706 pubmed publisher

Schopperle W, DeWolf W. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells. 2007;25:723-30 pubmed

Lajer H, Daugaard G, Andersson A, Skakkebaek N. Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer. Int J Cancer. 2002;100:244-6 pubmed